Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children

E Baraldi1, C Dario, R Ongaro

  • 1Departments of Pediatrics and Anesthesia and Intensive Care, University of Padova, School of Medicine, Padova, Italy. eugi@child.pedi.unipd.it

Insights

Infants with recurrent wheeze exacerbation show elevated exhaled nitric oxide (ENO) levels, indicating airway inflammation. These levels decrease significantly after steroid therapy, suggesting early disease activity in young children.

Area of Science:

  • Pediatric Pulmonology
  • Biomarkers of Airway Inflammation
  • Respiratory Medicine

Background:

  • Exhaled nitric oxide (ENO) is a known marker for asthma exacerbation in older children and adults.
  • Limited research exists on ENO levels in infants and young children experiencing recurrent wheeze exacerbations.

Purpose of the Study:

  • To investigate whether exhaled nitric oxide (ENO) levels are elevated in young children with recurrent wheeze exacerbation.
  • To assess the impact of oral prednisone therapy on ENO levels in this population.
  • To establish a method for measuring ENO in infants and young children.

Main Methods:

  • Exhaled nitric oxide (ENO) was measured using chemiluminescence in 13 young children with recurrent wheeze during acute episodes and after prednisone treatment.
  • Control groups included nine healthy children and six children with a first-time viral wheezy episode.
  • ENO measurements were validated by comparing pre- and post-intubation values in two healthy infants.

Main Results:

  • Children with recurrent wheeze exhibited significantly higher mean ENO levels (14.1 ppb) during exacerbation compared to healthy controls (5.6 ppb).
  • Following 5 days of oral prednisone, ENO levels in the recurrent wheeze group decreased by 52% (to 5.9 ppb).
  • Mean ENO levels in children with first-time wheeze (8.3 ppb) were lower than in those with recurrent wheeze.

Conclusions:

  • A reliable method for measuring exhaled nitric oxide (ENO) in infants and young children was established.
  • Elevated ENO levels during exacerbations in young children with recurrent wheeze suggest early-stage airway inflammation.
  • The rapid reduction in ENO after steroid therapy supports its role as an indicator of inflammatory activity in early wheeze.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...